Tramadol HCl Extended-Release Articles
Labopharm's once-daily Ryzolt cleared by FDA
12 January 2009
Labopharm hit by second FDA letter
11 June 2007
Biovail's 2005 revenue reaches $936M
3 April 2006
Showing 1-3 of 3 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
